| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2011PLoSO...627008J |
| P356 | DOI | 10.1371/JOURNAL.PONE.0027008 |
| P932 | PMC publication ID | 3206888 |
| P698 | PubMed publication ID | 22073238 |
| P5875 | ResearchGate publication ID | 51786700 |
| P2093 | author name string | Wei Wu | |
| Da Fu | |||
| Xing Zhong Wu | |||
| Yi Wei Dong | |||
| Qian Lei Zhao | |||
| Cheng You Jia | |||
| Hui Hui Li | |||
| Xu Chao Zhu | |||
| P2860 | cites work | Endothelial p70 S6 kinase 1 in regulating tumor angiogenesis. | Q53450181 |
| N-all-trans-retinoyl-L-proline inhibits metastatic potential of hepatocellular carcinoma cells. | Q53614855 | ||
| Studies on the relationship between protein kinase C and differentiation of human promyelocytic leukemia cells induced by retinoic acid | Q69387739 | ||
| Detection of PML-RAR alpha in patients with APL during follow-up period | Q71398815 | ||
| Lentiviral vector-mediated expression of pre-miRNAs and antagomiRs | Q83181879 | ||
| Potential role of miR-9 and miR-223 in recurrent ovarian cancer | Q21245724 | ||
| Real-time quantification of microRNAs by stem-loop RT-PCR | Q24535510 | ||
| MicroRNA-223 regulates cyclin E activity by modulating expression of F-box and WD-40 domain protein 7 | Q24621432 | ||
| MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis | Q24649761 | ||
| The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation | Q24655603 | ||
| MicroRNAs modulate hematopoietic lineage differentiation | Q27860661 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| Vertebrate microRNA genes | Q28181605 | ||
| Micro-RNA profiling in kidney and bladder cancers | Q28247306 | ||
| Regulation of progenitor cell proliferation and granulocyte function by microRNA-223 | Q28510667 | ||
| Many roads to maturity: microRNA biogenesis pathways and their regulation | Q29615469 | ||
| A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference | Q29615920 | ||
| A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis | Q29619201 | ||
| Inhibition of the insulin-like growth factor-1 receptor (IGF1R) tyrosine kinase as a novel cancer therapy approach | Q33925323 | ||
| An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling. | Q34625798 | ||
| Epigenetic silencing of the myelopoiesis regulator microRNA-223 by the AML1/ETO oncoprotein. | Q34712578 | ||
| MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. | Q34786558 | ||
| Targeting the PI3K/Akt/mTOR pathway: effective combinations and clinical considerations | Q36742629 | ||
| Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia. | Q37642294 | ||
| MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity | Q39893180 | ||
| Insulin-like growth factor I induces MDM2-dependent degradation of p53 via the p38 MAPK pathway in response to DNA damage | Q40747113 | ||
| A novel function of microRNA let-7d in regulation of galectin-3 expression in attention deficit hyperactivity disorder rat brain | Q42664377 | ||
| Protein kinase C in the promyelocytic leukemia cell differentiation of granulocytes | Q43638555 | ||
| Lactosylsulfatide expression in hepatocellular carcinoma cells enhances cell adhesion to vitronectin and intrahepatic metastasis in nude mice | Q44880124 | ||
| Serum 3'-sulfo-Lea indication of gastric cancer metastasis. | Q46036957 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e27008 | |
| P577 | publication date | 2011-11-02 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | MiR-223 suppresses cell proliferation by targeting IGF-1R. | |
| P478 | volume | 6 |
| Q47096258 | Altered miR-223 Expression in Sputum for Diagnosis of Non-Small Cell Lung Cancer |
| Q35690791 | Analysis of Deregulated microRNAs and Their Target Genes in Gastric Cancer. |
| Q58780065 | Biological Aspects of mTOR in Leukemia |
| Q41338350 | Circulating MicroRNA Let-7d in Attention-Deficit/Hyperactivity Disorder |
| Q38756678 | Circulating miR-223 in Oral Cancer: Its Potential as a Novel Diagnostic Biomarker and Therapeutic Target |
| Q92172431 | Circulating microRNAs (miR-126, miR-197, and miR-223) are associated with chronic kidney disease among elderly survivors of the Great East Japan Earthquake |
| Q26749533 | Clinical significance of microRNAs in chronic and acute human leukemia |
| Q40863376 | Construction and identification of recombinant lentivirus vector for microRNA-223 overexpression and suppression |
| Q35064121 | Decoy oligonucleotide rescues IGF1R expression from MicroRNA-223 suppression |
| Q54236665 | Decreased circulating microRNA-223 level predicts high on-treatment platelet reactivity in patients with troponin-negative non-ST elevation acute coronary syndrome. |
| Q54090322 | Decreased expression of microRNA-223 promotes cell proliferation in hepatocellular carcinoma cells via the insulin-like growth factor-1 signaling pathway. |
| Q35602216 | Down-regulation of microRNA-223 promotes degranulation via the PI3K/Akt pathway by targeting IGF-1R in mast cells |
| Q26766068 | Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma |
| Q26827810 | Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. |
| Q38007998 | Exploiting p70 S6 kinase as a target for ovarian cancer |
| Q43467395 | Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia |
| Q39166823 | Gain-of-function mutant p53 downregulates miR-223 contributing to chemoresistance of cultured tumor cells. |
| Q53061705 | Genetic association of gastric cancer with miRNA clusters including the cancer-related genes MIR29, MIR25, MIR93 and MIR106: results from the EPIC-EURGAST study. |
| Q51119596 | Identification of a microRNA landscape targeting the PI3K/Akt signaling pathway in inflammation-induced colorectal carcinogenesis. |
| Q34524873 | Increase of circulating miR-223 and insulin-like growth factor-1 is associated with the pathogenesis of acute ischemic stroke in patients |
| Q38996212 | Increased miR-223 expression in T cells from patients with rheumatoid arthritis leads to decreased insulin-like growth factor-1-mediated interleukin-10 production |
| Q35836584 | Inhibiting inducible miR-223 further reduces viable cells in human cancer cell lines MCF-7 and PC3 treated by celastrol |
| Q34442762 | MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R. |
| Q44719845 | MiR-223 downregulation promotes glomerular endothelial cell activation by upregulating importin α4 and α5 in IgA nephropathy |
| Q35046636 | MiR-223 regulates human embryonic stem cell differentiation by targeting the IGF-1R/Akt signaling pathway |
| Q34978831 | MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R |
| Q35657534 | MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells |
| Q37580204 | MiR-223-5p works as an oncomiR in vulvar carcinoma by TP63 suppression. |
| Q52663251 | MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization. |
| Q64993818 | MiR-99b-5p and miR-203a-3p Function as Tumor Suppressors by Targeting IGF-1R in Gastric Cancer. |
| Q36915053 | MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas |
| Q27027546 | MicroRNA and signal transduction pathways in tumor radiation response |
| Q46540341 | MicroRNA-182 plays an onco-miRNA role in cervical cancer. |
| Q92965397 | MicroRNA-223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes |
| Q35180264 | MicroRNA-223 delivered by platelet-derived microvesicles promotes lung cancer cell invasion via targeting tumor suppressor EPB41L3. |
| Q36953284 | MicroRNA-223 promotes mast cell apoptosis by targeting the insulin-like growth factor 1 receptor |
| Q52613070 | MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1. |
| Q39351860 | MicroRNA-223 regulates FOXO1 expression and cell proliferation |
| Q99611342 | MicroRNA-223 decreases cell proliferation, migration, invasion and enhances cell apoptosis in childhood acute lymphoblastic leukemia via targeting Forkhead box O1 |
| Q37395296 | MicroRNA-34a suppresses cell proliferation by targeting LMTK3 in human breast cancer mcf-7 cell line |
| Q36602853 | MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid Malignancies |
| Q38940592 | MicroRNAs and Inflammation in Colorectal Cancer |
| Q47664260 | MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer |
| Q37380881 | MicroRNAs transfer from human macrophages to hepato-carcinoma cells and inhibit proliferation |
| Q39881866 | Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223. |
| Q37117314 | Overexpression of miR-223 Tips the Balance of Pro- and Anti-hypertrophic Signaling Cascades toward Physiologic Cardiac Hypertrophy |
| Q45881243 | Overexpression of microRNA-223 in rheumatoid arthritis synovium controls osteoclast differentiation |
| Q37267161 | Porcine milk-derived exosomes promote proliferation of intestinal epithelial cells |
| Q53522472 | Post-transcriptional regulation of the tumor suppressor miR-139-5p and a network of miR-139-5p-mediated mRNA interactions in colorectal cancer. |
| Q34936657 | Regulation of IGF -1 signaling by microRNAs |
| Q35905574 | Reversal of MicroRNA Dysregulation in an Animal Model of Pulmonary Hypertension |
| Q36509109 | Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular Carcinoma |
| Q49639919 | Serum microRNA expression profiling in patients with multiple system atrophy. |
| Q37392772 | Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells |
| Q38364871 | Targeting PI3K/AKT/mTOR network for treatment of leukemia. |
| Q26801874 | The Emerging Role of miR-223 in Platelet Reactivity: Implications in Antiplatelet Therapy |
| Q26995383 | Tumor suppressor microRNAs: a novel non-coding alliance against cancer |
| Q38824206 | Tumor-suppressive microRNA-223 inhibits cancer cell migration and invasion by targeting ITGA3/ITGB1 signaling in prostate cancer |
| Q34722597 | Upregulation of miR-150* and miR-630 induces apoptosis in pancreatic cancer cells by targeting IGF-1R. |
| Q38439870 | XCI-escaping gene KDM5C contributes to ovarian development via downregulating miR-320a. |
| Q42114395 | miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells |
| Q38792762 | miR-223 contributes to the AGE-promoted apoptosis via down-regulating insulin-like growth factor 1 receptor in osteoblasts |
| Q36983803 | miR-223 enhances the sensitivity of non-small cell lung cancer cells to erlotinib by targeting the insulin-like growth factor-1 receptor |
| Q37211611 | miR-223 functions as a potent tumor suppressor of the Lewis lung carcinoma cell line by targeting insulin-like growth factor-1 receptor and cyclin-dependent kinase 2 |
| Q37439422 | miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions |
| Q42362761 | miR-223 promotes colon cancer by directly targeting p120 catenin |
| Q36734194 | miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway |
| Q55026266 | miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach. |
| Q38114927 | miR-223: infection, inflammation and cancer |
| Q34277279 | miR-34a inhibits migration and invasion of tongue squamous cell carcinoma via targeting MMP9 and MMP14. |
| Q50248848 | miRNA-223-3p regulates NLRP3 to promote apoptosis and inhibit proliferation of hep3B cells |
Search more.